HEM Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jul '26 Jul 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	297,453	327,494	114,874
Market Cap Growth	93.53%	185.09%	-
Enterprise Value	304,701	334,986	-
Last Close Price	41450.00	45850.00	16500.00
PS Ratio	20.64	25.23	7.62
PB Ratio	171.63	62.80	4.40
P/TBV Ratio	-	92.81	4.54
EV/Sales Ratio	21.14	25.81	-
Debt / Equity Ratio	11.21	3.69	0.30
Net Debt / Equity Ratio	4.02	1.05	-0.13
Net Debt / EBITDA Ratio	-0.48	-0.42	0.66
Net Debt / FCF Ratio	-0.39	-0.30	0.28
Asset Turnover	0.32	0.29	-
Inventory Turnover	12.82	9.97	-
Quick Ratio	0.34	0.38	1.73
Current Ratio	0.48	0.56	1.91
Return on Equity (ROE)	-194.38%	-151.43%	-
Return on Assets (ROA)	-23.77%	-21.96%	-
Return on Capital Employed (ROCE)	-218.20%	-137.30%	-27.60%
Earnings Yield	-8.61%	-7.28%	-6.66%
FCF Yield	-5.98%	-5.53%	-10.77%
Buyback Yield / Dilution	-8.40%	-10.68%	-